Company profile: MetaStat
1.1 - Company Overview
Company description
- Provider of diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MetaStat
KisoJi Biotechnology
HQ: Canada
Website
- Description: Provider of biotechnology solutions for healthcare and life sciences R&D, offering KisoMouse, a transgenic mouse platform for single-domain antibodies; KisoSeek, an NGS- and AI-guided structural antibody screening tool; KisoBody, a multi-functional, multi-specific antibody format; and therapeutic candidates including KJ-103 (TROP2, IND-enabling, solid tumors), KJ-101 (PD1/CD47/D2, IND-enabling), and KJ-102 (PD1/CD47/CD36, research, AML).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KisoJi Biotechnology company profile →
Zionexa
HQ: United States
Website
- Description: Provider of in-vivo biomarkers developed and commercialized to guide targeted therapies in oncology, aiming to improve patients' pathway and quality of life.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zionexa company profile →
Profound Medical
HQ: Canada
Website
- Description: Provider of medical device solutions for MRI-guided ablation in prostate care, offering TULSA-PRO, a transurethral ultrasound ablation system under MRI guidance; Sonalleve, a HIFU therapy platform for non-invasive treatment of uterine fibroids and palliative bone metastases pain; and PRO-Talk, an educational platform with learning resources for physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Profound Medical company profile →
Traws Pharma
HQ: United States
Website
- Description: Provider of clinical-stage small molecule oral therapies, including investigational inhibitors for COVID-19 (TRX01/ratutrelvir) and pandemic influenza (TRX100/tivoxavir marboxil), and narazaciclib, a proprietary multi-kinase CDK4-plus inhibitor in trials for refractory endometrial and metastatic breast cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Traws Pharma company profile →
Clinical Laserthermia Systems
HQ: Sweden
Website
- Description: Provider of the TRANBERG® Thermal Therapy System and disposable materials for image-guided, minimally invasive laser ablation and heat-induced immunotherapy (imILT®), offering focal therapy for localized prostate cancer, careful therapy of brain lesions/epileptogenic foci, immune-stimulating laser ablation, and the Thermoguide Workstation for real-time treatment monitoring and control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Laserthermia Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MetaStat
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MetaStat
2.2 - Growth funds investing in similar companies to MetaStat
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MetaStat
4.2 - Public trading comparable groups for MetaStat
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →